Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve the standalone and ....
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
OneSource Specialty Pharma Limited (formerly Stelis Biopharma Limited) has informed the exchanges that its Board of Directors will meet on Monday, August 4, 2025, at 5:30 PM IST. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). The company has also reminded that the trading window for designated persons is closed from July 1, 2025 and will reopen 48 hours after the results are published. The filing was made by Trisha A, Company Secretary and Compliance Officer, under SEBI Listing Regulations.
This is a routine procedural filing with no direct impact on the stock. Investors should watch for the actual Q1 results on August 4, 2025, as they could influence short-term price movement depending on performance versus expectations.